Hot Investor Mandate 3: Pharma Firm Invests in Therapeutic Assets in Oncology, Autoimmune, Diabetes and Infectious Disease

24 Nov

A large pharmaceutical firm based in China is currently seeking innovations in therapeutics field. The firm is open to collaborative research, licensing, equity investment and M&A opportunities. The firm has no set limit regarding the size of investment. The firm considers opportunities from across the world.

The firm considers oncology, autoimmune, diabetes, and infectious diseases. Within oncology, the firm focuses on gastric, breast, and liver cancer. The firm is open to all modalities of therapeutics and is opportunistic in terms of stage of development.

The firm is seeking competent management teams with strong sector expertise. The firm may request regional rights on a case-by-case basis.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: